DASATINIB
MSN · DASATINIB
Open FDA's page for this record- Application number
- ANDA219579
- Sponsor name
- MSN
- Submissions
- Submission type
- ORIG
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 20260911
- Review priority
- STANDARD
- Submission class code
- UNKNOWN
- Products
- Product number
- 005
- Reference drug
- No
- Brand name
- DASATINIB
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- DASATINIB
- Strength
- 100MG
- Product number
- 003
- Reference drug
- No
- Brand name
- DASATINIB
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- DASATINIB
- Strength
- 70MG
- Product number
- 001
- Reference drug
- No
- Brand name
- DASATINIB
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- DASATINIB
- Strength
- 20MG
- Product number
- 006
- Reference drug
- No
- Brand name
- DASATINIB
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- DASATINIB
- Strength
- 140MG
- Product number
- 004
- Reference drug
- No
- Brand name
- DASATINIB
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- DASATINIB
- Strength
- 80MG
- Product number
- 002
- Reference drug
- No
- Brand name
- DASATINIB
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- DASATINIB
- Strength
- 50MG
